Equities

Hoshi Iryo-Sanki Co Ltd

7634:TYO

Hoshi Iryo-Sanki Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)4,220.00
  • Today's Change-105.00 / -2.43%
  • Shares traded200.00
  • 1 Year change+8.62%
  • Beta0.3104
Data delayed at least 20 minutes, as of Nov 21 2024 04:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

HOSHI IRYO-SANKI CO., LTD. is a Japan-based company mainly engaged in the medical gas business and household medical business. The Company operates in five business segments. The Medical Gas-related segment is engaged in the sale of medical oxygen gas, anesthesia gas and other general medical gases. The Household Medical-related segment is engaged in the rental and sale of oxygen generator for home use, equipment for continuous positive pressure respiratory therapy, home respirators and others. The Medical Gas Equipment Work-related segment is engaged in the design and construction of medical gas piping works, and the maintenance and inspection of medical gas plumbing facilities. The Nursing Welfare-related segment is engaged in the rental and sale of nursing welfare-related products, housing renovation, the operation of home-visit nursing and home care support offices, and related businesses. The Facility Care-related segment is engaged in the operation of pay nursing home and others.

  • Revenue in JPY (TTM)15.10bn
  • Net income in JPY1.41bn
  • Incorporated1974
  • Employees486.00
  • Location
    Hoshi Iryo-Sanki Co Ltd7-11-18, IriyaADACHI-KU 121-0836JapanJPN
  • Phone+81 338992101
  • Fax+81 338992333
  • Websitehttps://www.hosi.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Create Medic Co Ltd12.93bn888.98m8.76bn962.009.060.525.700.6772100.05100.051,446.831,742.180.68071.724.6413,440,170.004.683.005.453.5343.7645.366.884.603.47--0.050663.222.103.11-68.06-25.530.66271.12
DVx Inc47.25bn55.70m9.94bn316.00173.021.0921.230.21045.335.334,522.33842.242.0623.294.13149,530,700.000.24323.110.58267.5710.2211.600.11791.491.42--0.0047.57-3.442.57-81.53-29.2311.2315.81
EcoNaviSta Inc1.20bn281.96m10.40bn35.0040.883.2234.448.6838.6538.65170.53490.670.38961.5218.3634,260,280.009.16--9.85--66.17--23.51--15.45--0.00--21.55--38.02------
JMS Co Ltd67.87bn-36.00m11.03bn5.28k--0.27022.900.1625-1.47-1.472,772.011,650.800.82132.643.8012,847,620.00-0.05081.33-0.07381.9721.9524.29-0.06191.571.070.54190.383243.312.432.38-112.81---2.421.22
OLBA Healthcare Holdings Inc120.11bn1.50bn12.73bn1.35k8.051.096.120.106252.91252.9120,250.401,863.862.8316.304.8088,710,020.003.533.0011.8910.3711.5011.291.251.040.9459742.060.21432.627.331.996.0914.11-2.5814.87
Seed Co Ltd33.28bn1.69bn14.04bn962.007.480.79992.870.42262.0462.041,188.74580.100.70452.807.7834,592,670.003.651.996.063.5143.1342.315.182.740.794911.280.596239.565.891.90721.4415.3020.424.56
HOSHI IRYO-SANKI CO., LTD15.10bn1.41bn14.79bn486.009.580.75911.980.9796451.24451.244,843.615,697.900.666727.375.9731,069,800.006.285.667.797.1948.8049.049.428.653.08--0.0016.347.256.4212.0110.04-13.238.45
Kusurinomadoguchi Inc9.91bn897.35m14.95bn505.0016.132.167.201.5184.4384.43943.55630.970.5277--3.0319,623,970.004.71--15.84--57.76--8.92----31.520.034--17.53--122.49------
Daiken Medical Co Ltd9.84bn1.06bn15.89bn175.0013.531.9712.381.6136.8936.89342.51253.630.86933.903.8756,226,790.009.367.4413.2510.8441.3341.7410.779.281.90301.850.252771.356.713.0138.843.03-4.010.9806
Techno Medica Co Ltd10.34bn1.19bn15.94bn237.0010.890.927212.251.54167.16167.161,442.431,962.830.60312.254.4543,647,340.006.966.688.047.8049.9848.8611.5312.314.51138.020.0039.339.781.9617.154.190.71687.67
Japan Medical Dynamic Marketing, INC.24.04bn1.41bn16.18bn511.0011.420.64835.230.672853.4953.49913.02942.480.78060.67184.5347,051,430.004.716.515.447.5363.4166.976.048.881.82--0.089518.338.786.74-10.68-8.52-2.959.24
Medius Holdings Co Ltd268.79bn1.11bn17.35bn2.52k15.530.89255.800.064550.2450.2412,186.68873.942.4918.804.97106,790,700.001.031.733.986.3411.9111.830.41120.65650.9191--0.563728.328.675.62-24.92--16.488.45
Medical Data Vision Co Ltd6.06bn4.79m17.49bn262.003,484.294.48244.692.890.12540.1254158.5997.571.12252.238.5323,120,150.00-0.465216.16-0.636720.8875.6881.90-0.414715.522.594.570.0019.985.1512.4012.4869.75-23.95--
Japan Tissue Engineering Co., Ltd.2.43bn-70.51m19.78bn211.00--3.38263.068.14-1.74-1.7459.82144.180.36634.635.3811,513,990.00-1.06-4.72-1.19-5.3163.2957.30-2.90-16.387.97-295.270.00--23.701.29119.63--30.22--
Data as of Nov 21 2024. Currency figures normalised to Hoshi Iryo-Sanki Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

3.12%Per cent of shares held by top holders
HolderShares% Held
Gesiuris Asset Management SGIIC SAas of 30 Jun 202444.70k1.31%
Fidelity Management & Research Co. LLCas of 31 Jan 202442.20k1.23%
Fidelity Investments Canada ULCas of 30 Sep 202410.00k0.29%
Dimensional Fund Advisors LPas of 31 Jul 20249.90k0.29%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.